Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCTD10P1 (Potassium channel tetramerization domain containing 10 pseudogene 1) is an approved human gene symbol for a pseudogene located in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode functional proteins due to loss-of-function mutations or lack of transcriptional activity. KCTD10P1 shares sequence similarity with the protein-coding KCTD10 gene, but there is no evidence it encodes a protein or participates in any known ion channel activity or cellular process.\n\nKCTD10P1 does not belong to classic families such as ion channels, receptors, enzymes, or transcription factors; rather, it is classified as a pseudogene. There is no evidence in available databases or literature indicating any biological function, disease role, biomarker utility, drug interactions, or safety concerns for KCTD10P1. It is not considered a therapeutic target, and cataloging it as one would be incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium channel tetramerization domain containing 10 pseudogene 1 (KCTD10P1).